|
|
||||||||
Gastrointestinal Imaging |
1 From the Departments of Radiology (S.K., J.H.O., M.S.P., J.V.F., R.L.B.) and Transplantation Medicine (B.S.C.), University of Pittsburgh Medical Center, 200 Lothrop St, Pittsburgh, PA 15213. Received November 11, 1999; revision requested December 15; revision received January 7, 2000; accepted January 12. Address correspondence to S.K. (e-mail: katyal@pitt.edu)
PURPOSE: To determine the relative frequency, incidence, and locations of metastases of hepatocellular carcinoma (HCC), correlate extrahepatic metastatic disease with intrahepatic tumor staging, and determine the computed tomographic (CT) manifestations of HCC metastases.
MATERIALS AND METHODS: CT findings in 403 consecutive patients with HCC at our institution since 1992 were reviewed retrospectively. One hundred forty-eight patients with extrahepatic metastatic HCC were identified, and the locations, sizes, and attenuation and enhancement characteristics of the lesions were recorded.
RESULTS: A majority (128 [86%] of 148) of patients with extrahepatic HCC foci had either intrahepatic stage IVA tumor (112 [76%] patients) or an intrahepatic stage III tumor (16 [11%] patients) at the occurrence of metastases. The most frequent site of the first detectable metastasis was the lung (58 [39%] patients). Tabulation of all extrahepatic metastatic sites showed the most common to be the lung in 81 (55%) patients, the abdominal lymph nodes in 60 (41%) patients, and the bone in 41 (28%) patients.
CONCLUSION: The lung, abdominal lymph nodes, and bone are the most common sites of extrahepatic metastatic HCC. Most extrahepatic HCC occurs in patients with advanced intrahepatic tumor stage (stage IVA). Incidental extrahepatic lesions at CT in patients with stage I or II intrahepatic HCC are unlikely to represent metastatic HCC.
Index terms: Liver, CT, 761.12111, 761.12112, 761.12115 Liver neoplasms, metastases, 761.323 Liver neoplasms, staging, 761.323
This article has been cited by other articles:
![]() |
A. Pai and A. Lin Chronic Asymptomatic Hepatitis B Presenting With Metastatic Hepatocellular Carcinoma J. Clin. Oncol., September 1, 2008; 26(25): 4209 - 4211. [Full Text] [PDF] |
||||
![]() |
M. Kawamura, J. Nakajima, H. Matsuguma, H. Horio, S. Miyoshi, K. Nakagawa, T. Fujisawa, K. Kobayashi, and The Metastatic Lung Tumor Study Group of Japan Surgical outcomes for pulmonary metastases from hepatocellular carcinoma. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 196 - 199. [Abstract] [Full Text] [PDF] |
||||
![]() |
H C KIM, D M YANG, W JIN, G Y KIM, and S I CHOI Metastasis to the appendix from a hepatocellular carcinoma manifesting as acute appendicitis: CT findings Br. J. Radiol., July 1, 2008; 81(967): e194 - e196. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sasaki, S. Kai, Y. Endo, K. Iwaki, H. Uchida, K. Shibata, M. Ohta, and S. Kitano Hepatitis B Virus Infection Predicts Extrahepatic Metastasis After Hepatic Resection in Patients With Large Hepatocellular Carcinoma Ann. Surg. Oncol., November 1, 2007; 14(11): 3181 - 3187. [Abstract] [Full Text] [PDF] |
||||
![]() |
C.-l. Ho, S. Chen, D. W.C. Yeung, and T. K.C. Cheng Dual-Tracer PET/CT Imaging in Evaluation of Metastatic Hepatocellular Carcinoma J. Nucl. Med., June 1, 2007; 48(6): 902 - 909. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Sasaki, K. Ishikawa, N. Haraguchi, H. Inoue, T. Ishio, K. Shibata, M. Ohta, S. Kitano, and M. Mori Receptor Activator of Nuclear Factor-{kappa}B Ligand (RANKL) Expression in Hepatocellular Carcinoma With Bone Metastasis Ann. Surg. Oncol., March 1, 2007; 14(3): 1191 - 1199. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-C. Zeng, Z.-Y. Tang, J. Fan, J. Zhou, L.-X. Qin, S.-L. Ye, H.-C. Sun, B.-L. Wang, J.-Y. Zhang, Y. Yu, et al. Radiation Therapy for Adrenal Gland Metastases from Hepatocellular Carcinoma Jpn. J. Clin. Oncol., February 1, 2005; 35(2): 61 - 67. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Ishii, J. Furuse, T. Kinoshita, M. Konishi, T. Nakagohri, S. Takahashi, N. Gotohda, K. Nakachi, and M. Yoshino Extrahepatic Spread from Hepatocellular Carcinoma: Who are Candidates for Aggressive Anti-cancer Treatment? Jpn. J. Clin. Oncol., December 1, 2004; 34(12): 733 - 739. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. H. Y. Lee, M. E. O'Malley, J. R. Kachura, M. Haider, and A. Hanbidge Hepatocellular Carcinoma: Imaging and Imaging-Guided Intervention Am. J. Roentgenol., April 1, 2003; 180(4): 1015 - 1022. [Full Text] [PDF] |
||||
![]() |
S. M. Hussain, P. E. Zondervan, J. N. M. IJzermans, S. W. Schalm, R. A. de Man, and G. P. Krestin Benign versus Malignant Hepatic Nodules: MR Imaging Findings with Pathologic Correlation RadioGraphics, September 1, 2002; 22(5): 1023 - 1036. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. K. Pannu, W. R. Maley, and E. K. Fishman Liver Transplantation: Preoperative CT Evaluation RadioGraphics, October 1, 2001; 21(90001): S133 - 146. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Chopra, G. D. Dodd III, K. N. Chintapalli, J. R. Leyendecker, O. I. Karahan, and H. Rhim Tumor Recurrence After Radiofrequency Thermal Ablation of Hepatic Tumors: Spectrum of Findings on Dual-Phase Contrast-Enhanced CT Am. J. Roentgenol., August 1, 2001; 177(2): 381 - 387. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| RADIOLOGY | RADIOGRAPHICS | RSNA JOURNALS ONLINE |